Important considerations in pregnant patients with lupus nephritis

Expert Review of Clinical Immunology
Gabriella Moroni, Claudio Ponticelli

Abstract

In the last few decades, identification of predictors of pregnancy outcome and appropriate pregnancy planning have significantly reduced the maternal and fetal risks in pregnant women with lupus nephritis. Areas covered: Successful pregnancies have been reported even in women with chronic renal disease and renal insufficiency. However, refractory hypertension and severe renal or cardiac chronic dysfunction are still considered contraindications to pregnancy. Pre-term delivery and fetal growth restriction may still occur in SLE patients more frequently than in healthy women, even in pregnancies regularly planned and monitored by a team of nephrologists and gynaecologists. Expert commentary: Stable disease remission is the most important factor for a successful pregnancy. In case of flare-ups of lupus, timely diagnosis and appropriate management may ensure a successful outcome in the majority of pregnant women. The negative role of anti-phospholipid antibodies and of chronic arterial hypertension may be countered with appropriate anticoagulation and anti-hypertensive therapy. Further studies are needed to better assess the possible impact of pregnancy on the long-term outcome of lupus nephritis.

References

Apr 1, 1987·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G BobrieP Jungers
Aug 1, 1980·Kidney International·J P Hayslett, R I Lynn
Dec 1, 1994·QJM : Monthly Journal of the Association of Physicians·D Le Thi HuongP Godeau
Mar 1, 1996·American Journal of Obstetrics and Gynecology·L A MageeG Koren
Jul 3, 1999·European Journal of Obstetrics, Gynecology, and Reproductive Biology·F CarmonaJ Balasch
Sep 15, 2000·Rheumatology·P E GeorgiouA A Drosos
Feb 24, 2001·Lancet·H SajiR Ijiri
May 15, 2001·Annals of the Rheumatic Diseases·D L HuongJ C Piette
Sep 27, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Gabriella MoroniClaudio Ponticelli
Jul 26, 1962·The New England Journal of Medicine·M GARSENSTEINR M KARK
Mar 31, 2004·Archives of Gynecology and Obstetrics·Farooq Z RahmanM Sayedur Rahman
Dec 14, 2004·Arthritis and Rheumatism·Anu TandonMurray B Urowitz
Feb 5, 2005·Arthritis and Rheumatism·Megan E B ClowseMichelle Petri
Mar 12, 2005·American Journal of Reproductive Immunology : AJRI·Francisco CarmonaJuan Balasch
Sep 24, 2005·Lupus·M E B ClowseM Petri
Jun 9, 2006·The New England Journal of Medicine·William O CooperWayne A Ray
Nov 1, 2006·Arthritis and Rheumatism·Megan E B ClowseMichelle Petri
May 15, 2007·Rheumatic Diseases Clinics of North America·Megan E B Clowse
May 23, 2007·Clinical Rheumatology·Javier A CavallascaGustavo G Nasswetter
Jul 13, 2007·São Paulo Medical Journal = Revista Paulista De Medicina·Fernanda Garanhani de Castro SuritaJosé Guilherme Cecatti
Dec 7, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Jeffrey S GilbertJoey P Granger
May 6, 2008·American Journal of Obstetrics and Gynecology·Megan E B ClowseAndra H James
Jun 21, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Enrico ImbasciatiDaniele Marcelli
Nov 26, 2009·Autoimmunity Reviews·Martina Biggioggero, Pier Luigi Meroni
Dec 17, 2009·Clinical Reviews in Allergy & Immunology·Antonio BrucatoJill Buyon
Mar 17, 2010·The Journal of Rheumatology·Dafna D GladmanMurray B Urowitz
Aug 7, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Andrew SmythVesna D Garovic
Nov 26, 2010·Blood·Eliza F ChakravartyPamela Farmer
Nov 26, 2010·Obstetrics and Gynecology·Aline D do PradoBernardo L Horta
Jun 3, 2011·The Journal of Rheumatology·Kate BramhamCatherine Nelson-Piercy
Jan 27, 2012·Clinical Rheumatology·Miguel A SaavedraLuis J Jara
Feb 7, 2012·Arthritis and Rheumatism·M CassinaUNKNOWN Organization of Teratology Information Specialists Collaborative Research Group
Feb 10, 2012·American Journal of Medical Genetics. Part a·Maria HoeltzenbeinChristof Schaefer
Mar 6, 2012·Clinical Cardiology·Carolina ValdiviezoPamela Ouyang
Mar 20, 2012·Archives of Cardiovascular Diseases·Min MuFang-Biao Tao
Mar 22, 2012·Birth Defects Research. Part A, Clinical and Molecular Teratology·Sara C HyounAnthony R Scialli
Jan 26, 2013·Clinical Journal of the American Society of Nephrology : CJASN·Kate BramhamCatherine Nelson-Piercy

❮ Previous
Next ❯

Citations

Oct 6, 2021·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Yinghua ChenWeixin Hu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.